Literature DB >> 7834614

Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum.

M G Muto1, W R Welch, S C Mok, C A Bandera, P M Fishbaugh, S W Tsao, C C Lau, H M Goodman, R C Knapp, R S Berkowitz.   

Abstract

Histopathological evidence suggests that papillary serous carcinoma of the peritoneum (PSCP) may be multifocal in origin. Utilizing a PCR based method to detect tandem repeat polymorphisms in formalin fixed tissue, loss of heterozygosity at eight loci on chromosomes 1, 3, 4, and 17 was studied in six cases of PSCP. Loss of heterozygosity was assessed at between 5 and 11 tumor sites/patient. Allelic losses at 4 loci (1q32-qter, 3p14.3-21.1, 17q12, 17q21.3-23) were noted. Three cases demonstrated a different pattern of allelic loss at various anatomic sites within the same patient. In an additional case, a mutation of the p53 gene, detected by quantitative PCR followed by single-strand conformation polymorphism analysis, was detected in only 2 of 5 tumor sites. The pattern of allelic loss and the mutational pattern of the p53 gene varied at tumor sites within the same patient in 4 of 6 cases of PSCP. These findings are consistent with histopathological evidence that PSCP is multifocal in origin.

Entities:  

Mesh:

Year:  1995        PMID: 7834614

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Early detection of ovarian cancer.

Authors:  Partha M Das; Robert C Bast
Journal:  Biomark Med       Date:  2008-06       Impact factor: 2.851

2.  Photodynamic detection and management of intraperitoneal spreading of primary peritoneal papillary serous carcinoma in a man: report of a case.

Authors:  Emel Canbay; Haruaki Ishibashi; Shouzou Sako; Toshiyuki Kitai; Eisei Nishino; Masamitsu Hirano; Akiyoshi Mizumoto; Yoshio Endo; Shun-Ichiro Ogura; Yutaka Yonemura
Journal:  Surg Today       Date:  2013-02-23       Impact factor: 2.549

3.  Primary peritoneal serous carcinoma: a rare case and palliative approach.

Authors:  Viral M Bhanvadia; Jignesh K Parmar; Yogendra G Madan; Shamim S Sheikh
Journal:  Indian J Palliat Care       Date:  2014-05

4.  Extrauterine high-grade serous carcinomas with bilateral adnexal involvement as the only two disease sites are clonal based on tp53 sequencing results: implications for biology, classification, and staging.

Authors:  Naveena Singh; Asma Faruqi; Friedrich Kommoss; W Glenn McCluggage; Giorgia Trevisan; Janine Senz; Amy Lum; C Blake Gilks; Michael Anglesio
Journal:  Mod Pathol       Date:  2017-11-17       Impact factor: 7.842

5.  Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma.

Authors:  Andrea R Hagemann; Ian S Hagemann; Mark Cadungog; Wei-Ting Hwang; Priya Patel; Priti Lal; Rachel Hammond; Phyllis A Gimotty; Christina S Chu; Steven C Rubin; Michael J Birrer; Daniel J Powell; Michael D Feldman; George Coukos
Journal:  Cancer Biol Ther       Date:  2011-08-15       Impact factor: 4.742

Review 6.  Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.

Authors:  Murray Joseph Casey; Chhanda Bewtra
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

7.  Serous adenocarcinoma of the retroperitoneum, as a type of multifocal müllerian carcinoma.

Authors:  Ayaka Iura; Yuko Sasajima; Noriyuki Katsumata; Takahiro Kasamatsu
Journal:  Int J Clin Oncol       Date:  2009-07-11       Impact factor: 3.402

8.  Advanced primary peritoneal carcinoma: clinicopathological and prognostic factor analyses.

Authors:  Chao Zhang; Xiao-ping Li; Heng Cui; Dan-hua Shen; Li-hui Wei
Journal:  J Zhejiang Univ Sci B       Date:  2008-06       Impact factor: 3.066

9.  Rapidly increasing incidence of papillary serous carcinoma of the peritoneum in the United States: fact or artifact?

Authors:  Marc T Goodman; Yurii B Shvetsov
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

Review 10.  Peritoneal carcinomatosis.

Authors:  Federico Coccolini; Federico Gheza; Marco Lotti; Salvatore Virzì; Domenico Iusco; Claudio Ghermandi; Rita Melotti; Gianluca Baiocchi; Stefano Maria Giulini; Luca Ansaloni; Fausto Catena
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.